Search for a rare disease
Other search option(s)
NMDA receptor encephalitis
Disease definition
A rare limbic encephalitis characterized by the presence of autoantibodies against NMDA receptors in serum and cerebrospinal fluid. It may be of paraneoplastic (most commonly associated with ovarian teratoma) or non-paraneoplastic origin and is life-threatening but potentially treatable. Patients present with acute behavioral change, psychosis, and catatonia, rapidly progressing to seizures, memory deficit, dyskinesias, speech problems, and autonomic and breathing dysregulation.
ORPHA:217253
Classification level: Disorder- Synonym(s):
- Limbic encephalitis with N-methyl-D-aspartate receptor antibodies
- Limbic encephalitis with NMDA receptor antibodies
- N-methyl-D-aspartate receptor encephalitis
- NMDARE
- anti-NMDA receptor encephalitis
- Prevalence: Unknown
- Inheritance: Not applicable
- Age of onset: All ages
- ICD-10: G13.1
- OMIM: -
- UMLS: C2986717
- MeSH: D060426
- GARD: -
- MedDRA: -
A summary on this disease is available in Deutsch (2020) Español (2020) Français (2020) Nederlands (2020)
Detailed information
General public
- Article for general public
- Svenska (2018) - Socialstyrelsen
Guidelines
- Clinical practice guidelines
- Deutsch (2012) - AWMF
- Français (2021) - PNDS
- Anesthesia guidelines
- English (2022) - Orphananesthesia
Disease review articles
- Review article
- English (2014) - Orphanet J Rare Dis


Additional information
Further information on this disease
Patient-centred resources for this disease
Research activities on this disease
Specialised Social Services
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.